Infinity Pharmaceuticals, Inc. (INFI): Price and Financial Metrics
INFI Price/Volume Stats
| Current price | $0.01 | 52-week high | $0.01 |
| Prev. close | $0.02 | 52-week low | $0.01 |
| Day low | $0.01 | Volume | 2,476,900 |
| Day high | $0.01 | Avg. volume | 0 |
| 50-day MA | N/A | Dividend yield | N/A |
| 200-day MA | N/A | Market Cap | 719.28K |
INFI Stock Price Chart Interactive Chart >
Infinity Pharmaceuticals, Inc. (INFI) Company Bio
Infinity Pharmaceuticals, Inc. discovers, develops, and delivers medicines to patients with difficult-to-treat diseases. Its lead product candidate includes IPI-145, an oral inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) for the treatment of hematologic malignancies. The company was founded in 2001 and is based in Cambridge, Massachusetts.
INFI Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
INFI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -98.78% |
| 5-year | -98.89% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -75.33% |
| 2021 | 6.13% |
| 2020 | 120.83% |